Detalhe da pesquisa
1.
NAFLD vs MAFLD: South Asian NAFLD Patients don't Favor Name Change.
Euroasian J Hepatogastroenterol
; 12(Suppl 1): S1-S4, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-36466103
2.
Observational study on the response of tenofovir monotherapy versus tenofovir plus telbivudine dual therapy in patients with hepatitis B virus related acute on chronic liver failure.
J Family Med Prim Care
; 10(6): 2376-2380, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-34322441
3.
Role of tenofovir and telbivudine in treatment of hepatitis B related acute on chronic liver failure.
J Family Med Prim Care
; 10(6): 2381-2385, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-34322442
4.
Comparative role of tenofovir versus entecavir for treating patients with hepatitis B virus-related acute on chronic liver failure.
J Family Med Prim Care
; 10(7): 2642-2645, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34568149
5.
Role of Pegylated Interferon in Patients with Chronic Liver Diseases in the Context of SARS-CoV-2 Infection.
Euroasian J Hepatogastroenterol
; 11(1): 27-31, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34316461
6.
HeberNasvac, a Therapeutic Vaccine for Chronic Hepatitis B, Stimulates Local and Systemic Markers of Innate Immunity: Potential Use in SARS-CoV-2 Postexposure Prophylaxis.
Euroasian J Hepatogastroenterol
; 11(2): 59-70, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34786358
7.
Tele-education for hepatology residents in Bangladesh during the Covid-19 pandemic.
J Family Med Prim Care
; 9(8): 4476-4477, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33110891